Effect of streptozotocin-induced diabetes on the autonomic ganglia of albino rats
Objectives: One of the common clinical observations regarding long-standing hyperglycemia is autonomic neuropathy, probably due to its unfavorable destructive effects on the neurons of the autonomic ganglia. Accordingly, the current study was aimed to analyze the effect of experimental hyperglycemia on parasympathetic pterygopalatine ganglion (PtG) and sympathetic coeliac ganglion (ClG) of albino rats.Methods: Thirty-six albino rats were divided into six groups (n=6, each) and were designated as control, two weeks, one month, two months, four months and six months groups. Diabetes was induced with a single dose of streptozotocin (STZ, 60 mg/kg, i.p.). Body weight and blood sugar were monitored at biweekly intervals. At the end of each experimental period, animals were euthanized by deep ether anesthesia and blood samples were collected by direct puncture of heart for biochemicalanalysis. Animals were perfused with Karnovsky fixative. After 48 hours, tissue samples were collected and processed for light microscopy.Results: Biochemical analysis of serum revealed increased serum creatinine and reduced serum total protein. Histopathology and histomorphometry of ganglia revealed that the progressively increasing duration of hyperglycemia was associated withdecreased proportion of small-sized neurons, increased proportion of large-sized neurons, dark and dead neurons, and thickening of capsular and endoneurial collagen.Conclusion: The association of the long-standing hyperglycemia with increased neuronal death, altered proportion of neurons and deposition of collagen fibers in autonomic ganglia appear to be important contributing factors likely to be responsible for diabetic autonomic neuropathy.
___
- 1. Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and
antioxidants: a review. J Biochem Mol Toxicol 2003;17:24–38.
2. Phillips M, Cataneo RN, Cheema T, Greenberg J. Increased breath
biomarker of oxidative stress in diabetes mellitus. Clin Chim Acta
2004;344:189–94.
3. Tomlinson DR, Gardiner NJ. Glucose neurotoxicity. Nat Rev
Neurosci 2008;9:36–45.
4. Guven A, Yavuz O, Cam M, Comunoglu C, Sevinc O. Central nervous
system complications of diabetes in streptozotocin-induced diabetic
rats: a histopathological and immunohistochemical examination.
Int J Neurosci 2009;119:1155–69.
5. Rudchenko A, Akude E, Cooper E. Synapses on sympathetic neurons
and parasympathetic neurons differ in their vulnerability to diabetes.
J Neurosci 2014;34:8865–74.
6. Srinivasan S, Stevens M, Wiley JW. Diabetic peripheral neuropathyevidence
for apoptosis and associated mitochondrial dysfunction.
Diabetes 2000;49:1932–8.
7. Fernyhough A, Chowdhury SKR, Schmidt RE. Mitochondrial stress
and the pathogenesis of diabetic neuropathy. Expert Rev Endocrinol
Metab 2010;5:39–49.
8. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic
neuropathy. Diabetes Care 2003;26:1553–79.
9. Siessere S, Vitti M, de Sousa, LG, Semprini M, Iyomasa MM,
Regalo SC. Anatomic variation of cranial parasympathetic ganglia.
Braz Oral Res 2008;22:101–5.
10. Sisu AM, Petrescu CI, Cebzan CC, Motoc A, Bolintineanu S, vaida
AM, Niculescu MC, Rusu MC. The adult coeliac ganglion: a morphologic
study. Rom J Morphol Embryol 2008;49:491–4.
11. Sasahara TH, De souza RR, Machado MR, Da silva RA, Guidi WL,
Ribeiro AA. Macro- and microstructural organization of the rabbit's
celiac-mesenteric ganglion complex (Oryctolagus cuniculus). Ann
Anat 2003;185:441–8.
12. Schmidt RE, Dorsey DA, Beaudet LN, Frederick KE, Parvin CA,
Plurad SB, Levisetti MG. Non-obese diabetic mice rapidly develop
dramatic sympathetic neuritic dystrophy a new experimental
model of diabetic autonomic neuropathy. Am J Pathol 2003;163:
2077–91.
13. Olsson Y, Sourander P. Changes in the sympathetic nervous system
in diabetes mellitus. J Neurovisc Relat 1968;81:86–95.
14. Faizal PAM, Khan AA, Elsy B. Effect of experimental hyperglycemia
on the trigeminal ganglia of albino rats. Int J Health Sci Res 2017;7:
191–8.
15. Young B, O’Dowd G, Woodford P. Wheater’s functional histology:
a text and colour atlas. 6th edition. Philadelphia (PA): Churchill
Livingstone, 2016. 139 p.
16. Ernst MC, Sinal CJ. Chemerin at the crossroads of inflammation
and obesity. Trends Endocrinol Metab 2010;21:660–7.
17. King KD, Jones JD, Warthen J. Microvascular and macrovascular
complications of diabetes mellitus. Am J Pharm Educ 2005;69:1–10.
18. Cheng D. Prevalence, predisposition and prevention of type II diabetes.
Nutr Metab (Lond) 2005;18:2–29.
19. Air EL, Strowski MZ, Benoit SC, Conarello SL, Salituro GM, Guan
XM, Liu K, Woods SC, Zhang BB. Small molecule insulin mimetics
reduce food intake and body weight and prevent development of
obesity. Nat Med 2002;8:179–83.
20. Jain D, Bansal MK, Dalvi R, Upganlawar A, Somani R. Protective
effect of diosmin against diabetic neuropathy in experimental rats. J
Integr Med 2014;12:35–41.
21. Cintra LTA, Samuel RO, Prieto AK, Sumida DH, Dezan-Junior E,
Gomes-Filho JE. Oral health, diabetes, and body weight. Arch Oral
Biol 2017;73:94–9.
22. Elsy B, Maheshwari V, Khan AA. Effects of d alpha-tocopherol on
progression of reepithelialization, matrix remodeling and appearance
of epidermal appendages in secondary skin wounds of diabetic rats.
Journal of Dermatology and Clinical Research 2016;4:1081.
23. Doddigarla Z, Ahmad J, Parwez I. Effect of chromium picolinate and
melatonin either in single or in a combination in high carbohydrate
diet?fed male Wistar rats. Biofactors 2016;42:106–14.
24. Elfvin LG. The ultrastructure of the superior cervical sympathetic
ganglion of the cat: I. The structure of the ganglion cell processes as
studied by serial sections. J Ultrastruct Res 1963;8:403–40.
25. Jurgaitiene R, Pauziene N, Azelis V, Zurauskas E. Morphometric
study of age-related changes in the human intracardiac ganglia.
Medicina (Kaunas) 2004;40:574–81.
26. Szczurkowski A, Kuder T, Nowak E, Kuchinka J. Morphology,
topography and cytoarchitectonics of the pterygopalatine ganglion
in Egyptian spiny mouse (Acomys cahirinus, Desmarest). Folia
Morphol (Warsz) 2002;61:107–10.
27. Dilkash MNA, Ahmed SS, Khan AA. Comparative light microscopic
study of trigeminal ganglion neurons in mammals. Curr Neurobiol
2010;1:25–9.
28. Adebiyi OA, Adebiyi OO, Owira PM. Naringin reduces hyperglycemia-
induced cardiac fibrosis by relieving oxidative stress. PloS
One 2016;11:1–15.
29. De Vriese AS, Flyvbjerg A, Mortier S, Tilton RG, Lameire NH.
Inhibition of the interaction of AGE-RAGE prevents hyperglycemiainduced
fibrosis of the peritoneal membrane. J Am Soc Nephrol
2003;14:2109–18.
30. Malak HW, Saleh SI, Salah El Din RA, Abdul Hamid HF.
Histological and immunohistochemical study on the consequences
of acute glycemic level alteration on the dorsal root ganglia and sciatic
nerve integrity in neonatal albino rats. Egyptian Journal of
Histology 2015;38:332–45.
31. Ahmadpour SH, Haghir H. Diabetes mellitus type 1 induces dark
neuron formation in the dentate gyrus: a study by Gallyas’ method
and transmission electron microscopy. Rom J Morphol Embryol
2011;52:575–9.
32. Zsombok A, Toth Z, Gallyas F. Basophilia, acidophilia and argyrophilia
of ‘dark’ (compacted) neurons during their formation, recovery
or death in an otherwise undamaged environment. J Neurosci
Methods 2005;142:145–52.
33. Krysko DV, Vanden Berghe T, D'Herde K, Vandenabeele P.
Apoptosis and necrosis: detection, discrimination and phagocytosis.
Methods 2008;44:205–21.
34. Keane RW, Kraydieh S, Lotocki G, Alonso OF, Aldana P, Dietrich
WD. Apoptotic and antiapoptotic mechanisms after traumatic brain
injury. J Cereb Blood Flow Metab 2001;21:1189–98.
35. Sango, K, Horie H, Saito H, Ajiki K, Tokashiki A, Takeshita K,
Ishigatsubo Y, Kawano H, Ishikawa Y. Diabetes is not a potent
inducer of neuronal cell death in mouse sensory ganglia, but it
enhances neurite regeneration in vitro. Life Sci 2002;71:2351–68.
36. Duchen LW, Scaravilli F. Quantitative and electron microscopic
studies of sensory ganglion cells of the Sprawling mouse. J
Neurocytol 1977;6:465–81.
37. Seylaz J, Hara H, Pinard E, Mraovitch S, MacKenzie ET, Edvinsson
L. Effect of stimulation of the sphenopalatine ganglion on cortical
blood flow in the rat. J Cereb Blood Flow Metab 1988;8:875–8.
38. Yasui T, Karita K, Izumi H, Tamai M. Correlation between vasodilatation
and secretion in the lacrimal gland elicited by stimulation of
the cornea and facial nerve root of the cat. Invest Ophthalmol Vis Sci
1997;38:2476–82.
39. Kaji A, Maeda T, Watanabe S. Parasympathetic innervation of cutaneous
blood vessels examined by retrograde tracing in the rat lower
lip. J Auton Nerv Syst 1991;32:153–8.
40. Yoon KC, Im SK, Seo MS. Changes of tear film and ocular surface
in diabetes mellitus. Korean J Ophthalmol 2004;18:68–74.
41. Postorino M, Catalano C, Martorano C, Cutrupi S, Marino C,
Cozzupoli P, Scudo P, Zoccali C. Salivary and lacrimal secretion is
reduced in patients with ESRD. Am J Kidney Dis 2003;42:722–8.
42. Gibbins IL, Morris JL. Structure of peripheral synapses: autonomic
ganglia. Cell Tissue Res 2006;326:205–26.
43. Hokfelt T, Elfvin LG, Elde R, Schultzberg M, Goldstein M, Luft R.
Occurrence of somatostatin-like immunoreactivity in some peripheral
sympathetic noradrenergic neurons. Proc Natl Acad Sci USA
1977;74:3587–91.
44. Gibbins IL. Vasomotor, pilomotor and secretomotor neurons distinguished
by size and neuropeptide content in superior cervical ganglia
of mice. J Auton Nerv Syst 1991;34:171–83.
45. Phillips LK, Rayner CK, Jones KL, Horowitz M. An update on autonomic
neuropathy affecting the gastrointestinal tract. Curr Diab Rep
2006;6:417–23.
46. Ding C, He QP, Li PA. Diabetes increases expression of ICAM after
a brief period of cerebral ischemia. J Neuroimmunol 2005;161:61–7.
47. Katz ML, Robison WG Jr. What is lipofuscin? Defining characteristics
and differentiation from other autofluorescent lysosomal storage
bodies. Arch Gerontol Geriatr 2002;34:169–84.
48. Sugaya A, Sugimioto H, Mogi N, Tsujigami H, Deguchi S.
Experimental diabetes accelerates accumulation of fluorescent pigments
in rat trigeminal neurons. Brain Res 2004;999:132–4.
49. Schmidt RE, Plurad SB, Parvin CA, Roth KA. Effect of diabetes and
aging on human sympathetic autonomic ganglia. Am J Pathol 1993;
143:143–53.
50. Ronco C, Grammaticopoulos S, Rosner M, De Cal M, Soni S,
Lentini P, Piccini P. Oliguria, creatinine and other biomarkers of
acute kidney injury. Contrib Nephrol 2010;164:118–27.
51. Sjöholm A, Nyström T. Inflammation and the etiology of type 2 diabetes.
Diabetes Metab Res Rev 2006;22:4–10.
52. Danielle AT de Almeida, Camila PB,. Ethel LBN, Ana Angelica HF.
Evaluation of lipid profile and oxidative stress in STZ-induced rats
treated with antioxidant vitamin. Brazilian Archieves of Biology and
Technology 2012;55:527–36.
53. Upchurch GR Jr, Keagy BA, Johnson G Jr. An acute phase reaction
in diabetic patients with foot ulcers. Cardiovasc Surg 1997;5:
32–6.